Buy Vita-D Vitamin D Injection Injection Vita-D 200000iu 300000iu Hycomin Vitamin B-12 B12 Shots Injections Hydroxocobalamin Deficiency Vitamin C D3

• Gender: Female
• Side Effect: No
• Usage: Double Chin, Belly Fat, Arm Fat, Thigh Fat
• Model NO.: Vita-D Vitamin D Hycomin Vitamin B12
• Pharmaceutical Technology: Chemical Synthesis
• Efficacy: Weight Loss & Slimming
• Product Name: The Red Lipolytic, Lipolab
• Package: 10ml *10PCS/Box
• Transport Package: Carton Transport
• Specification: 10ml
• Trademark: Mesocartin Injection L-Carnitine
• Origin: Korea
• HS Code: 3506100090
• Production Capacity: 10000

Product Description

Buy Vita-D Vitamin D Injection Injection Vita-D 200000IU 300000IU

Product Description

Vita-D Inj.  200,000IU

Component
Cholecalciferol (EP) in 1mL ----5mg (200,000 IU) [Solvent: medium-chain triglycerides (MCTs), Tocopherol(dl-α-Tocopherol)]

 

Identification

Colorless to greenish-yellow cholecalciferol emulsion in a brown glass ampoule

Efficacy / Effect
1. Prevention and treatment of vitamin D deficiency in the elderly and adolescents with a high risk of vitamin D deficiency
2. Prevention and treatment of vitamin D deficiency in adults at high risk of vitamin D deficiency with malabsorption

Dosage

Use according to the doctor's prescription but adjust the dose according to the level of 25-hydroxy vitamin D in the blood. Adverse reactions increase with overdose, so do not administer more than necessary.

Adult: As cholecalciferol, 200,000 IU is injected intramuscularly. Adolescent: As cholecalciferol, 200,000 IU is injected intramuscularly.

Elderly: As cholecalciferol, 100,000 IU is injected intramuscularly. The annual dose should not exceed 600,000 IU as cholecalciferol.

Precautions for use

1. Warning

1) To avoid overdose, take treatment containing vitamin D and food intake enhancing vitamin D level into consideration. 2) Observe calcium level; if the level of serum calcium exceeds 10.5mg/dl or urinary calcium in adults exceeds 4mg/kg day, stop dosing. 3) If calcium intake is high, regularly monitor the blood and calcium level.

2. Do not administer this drug to the following patients: 1) Patients with hypersensitivity to the components of this drug 2) Patients with hypercalcemia, hypercalciuria 3) Patients with calcium oxalate stones 4) Patients with renal impairment 5) Patients who are immobilized in a hospital bed 6) Sarcoidosis 7) Patients with pseudoparathyroidism

3. Adverse reaction 1) If overdose, the following adverse reactions may occur: Headache, asthenia, fatigue, muscle pain, Loss of appetite, weight loss, growth disorder, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, high blood pressure, calcium oxalate stones, tissue calcification, kidney disease, vascular disease, and kidney failure. In addition, hypercalcemia, hyperphosphatemia, and hyperphosphateuria may occur.

 

Storage / Shelf life

Hermetic container, store at room temperature (1~30 ºC ) in a Light-resistant / 36 months from the date of manufacture

Packing unit: 1mL * 5Amp.

 

Certifications